School of Public Health, Fudan University, Shanghai, China.
National Health Commission Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China.
Expert Rev Pharmacoecon Outcomes Res. 2022 Dec;22(8):1277-1283. doi: 10.1080/14737167.2022.2131542. Epub 2022 Oct 13.
This study seeks to assess the quality of HEEs reporting on screening programs over the last 20 years in China, to identify potential predictors of reporting quality.
We performed a literature search of HEE studies published in PubMed, Embase, CNKI, and WANFANG from 2000 to 2021. The search terms included 'screening,' 'China,' 'CEA,' 'CBA,' 'CUA,' and all other names for health economic evaluation. Two reviewers independently extracted data and assessed the reporting quality using CHEERS checklist. A generalized linear regression analysis was used to identify the predictors of reporting quality.
133 of 1,281 identified studies was included. The reporting quality scores showed an increasing trend and the mean score was 0.56. Some items were underreported, such as study perspective, discount rate, measurement of effectiveness, analytical methods, uncertainty, heterogeneity etc. Five factors (year of publication, journal type, first author's affiliation, economic evaluation type, specialty journals or not) predicted a higher score of reporting quality in the regression analyses (P < 0.05).
Overall, the quality of HEEs on screening programs in China showed an improving trend. Given the significance of reporting quality, it is advisable to report HEE results following standard evaluation guidelines to improve their transparency.
本研究旨在评估过去 20 年来中国卫生经济评价研究人员(HEE)在报告筛查项目方面的质量,并确定报告质量的潜在预测因素。
我们对 2000 年至 2021 年期间在 PubMed、Embase、CNKI 和 WANFANG 中发表的 HEE 研究进行了文献检索。检索词包括“screening”、“China”、“CEA”、“CBA”、“CUA”以及卫生经济评价的所有其他名称。两位评审员独立提取数据,并使用 CHEERS 清单评估报告质量。使用广义线性回归分析确定报告质量的预测因素。
从 1281 项中确定了 133 项研究。报告质量评分呈上升趋势,平均得分为 0.56。一些项目报告不足,如研究视角、贴现率、有效性测量、分析方法、不确定性、异质性等。五个因素(发表年份、期刊类型、第一作者所属单位、经济评价类型、是否为专业期刊)在回归分析中预测了更高的报告质量评分(P<0.05)。
总体而言,中国筛查项目卫生经济评价的质量呈上升趋势。鉴于报告质量的重要性,建议按照标准评估指南报告卫生经济评价结果,以提高其透明度。